We were pleased to announce our participation in the 2025 Annual Meeting of the Genetic Toxicology Association, taking place at the University of Delaware, Newark, from 7th to 9th May 2025. This year’s event showcased the latest scientific innovations in genotoxicity and carcinogenicity testing, with a focus on new approach methodologies (NAMs) and adverse outcome […]
2025 Genetic Toxicology Association Annual Meeting Read More »
We are delighted to collaborate with Codurance for an interactive session exploring the real impact of AI tooling in software development, in the Software Crafters Leeds Meetup. Join us at at the Lhasa office for an evening of hands-on challenges, insightful discussions, and networking. We’ll explore a topic that’s becoming increasingly central to modern software
AI Tooling in Software Development: Smarter Prompts for Smarter Code Read More »
We teamed up with the newly launched Wicked Digital and the team at Transition Partners to host this exiting panel discussion. The event welcomed tech leaders, innovators, and curious minds to explore how the next 12 months might unfold across digital and tech. Speakers explored how AI, automation, and next-gen platforms are already shaping industries.
Unpacking the innovations shaping the year ahead Read More »
Co-hosted with BITEK CHEMS on April 16th, this bilingual event was hosted in Korean, and include translated presentations from expert Lhasa and Consult Lhasa scientists. Experts David Ponting (Principal Scientist, Lhasa Limited) and Natan Segretti (CSO, Consult Lhasa) presented an explorative webinar on the recently updated EMA guidelines for nitrosoureas risk assessment. Natan provided
Nitrosoureas and beyond: What to do when the CPCA doesn’t apply – Korea Read More »
This bilingual event was hosted in Japanese, and included translated presentations from expert Lhasa and Consult Lhasa scientists. Experts David Ponting (Principal Scientist, Lhasa Limited) and Natan Segretti (CSO, Consult Lhasa) presented an explorative webinar on the recently updated EMA guidelines for nitrosoureas risk assessment. Natan provided a comprehensive overview of this critical regulatory
Nitrosoureas and beyond: What to do when the CPCA doesn’t apply – Japan Read More »
Thank you to everyone who came out for the Boost Talent 𝑩𝒓𝒊𝒅𝒈𝒊𝒏𝒈 𝒕𝒉𝒆 𝑮𝒂𝒑 workshop! It was fantastic to see so much enthusiasm from the tech community, engaging in important discussions and driving change.
Experts David Ponting (Principal Scientist, Lhasa Limited) and Natan Segretti (CSO, Consult Lhasa), delivered an explorative webinar on the recently updated EMA guidelines for nitrosoureas risk assessment. Natan provided a comprehensive overview of this critical regulatory update, explaining why nitrosoureas are classified within the cohort of concern and the reasoning behind these new regulatory
Nitrosoureas and beyond: What to do when the CPCA doesn’t apply Read More »
We were thrilled to participate in the 64th annual Society of Toxicology meeting in Orlando, Florida! This year’s program promised an engaging line-up of featured and scientific sessions, thought-provoking poster presentations and networking opportunities. Monday 17th March Session: Transforming Carcinogenicity Assessments with NAMs and Guided Expert Review. Lhasa Limited have been at the forefront of
Society of Toxicology 64th Annual Meeting Read More »
We were delighted to attend the 53rd OPRD conference in Charleston in 2025. The conference provided a platform for sharing scientific content around improving efficiency and learning how to be more innovative in synthetic route design, development and optimisation. The chemical and pharma industries are fast moving and ever changing and the efficient conversion of
53rd Organic Process Research and Development Read More »
Nitrosamines are emerging as a significant concern in the pharmaceutical industry, posing regulatory and safety challenges for manufacturers. Are you prepared to address these risks effectively? Our panel of expert speakers discussed why nitrosamines have become a growing concern and the latest regulatory developments in Argentina and Mexico. This webinar also introduced innovative in silico
Nitrosamines on the horizon: Are you ready? Read More »